REVIEW
|
doi:10.20944/preprints202310.0556.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
acute leukemia; chronic leukemia; cutis; diagnosis; pathogenesis; prolympchocytic leukemia; Richter transformation; skin lesions; treatment
Online: 10 October 2023 (05:36:42 CEST)
REVIEW
|
doi:10.20944/preprints202112.0282.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Acalabrutinib; Bruton’s tyrosine kinase; BTK; CLL; Covalent inhibitors; COVID-19; Ibrutinib; Non-covalent inhibitors; Fenebrutinib; MK1026; Pirtobrutinib; Spebrutinib; Tirabrutinib; Zanubrutinib
Online: 16 December 2021 (16:13:54 CET)
REVIEW
|
doi:10.20944/preprints202311.0714.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Anaplastic large cell lymphoma; Brentuximab vedotin; CD30 positive lymphomas; Diagnosis; Lymphomatoid papulosis; Primary cutaneous T-cell lymphoma; Treatment
Online: 13 November 2023 (08:27:17 CET)
REVIEW
|
doi:10.20944/preprints202110.0069.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biology; drug resistance; gene expression profiling; mRNA; multiple myeloma; prognosis; treatment
Online: 5 October 2021 (08:20:44 CEST)
ARTICLE
|
doi:10.20944/preprints202106.0092.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
BRAF; cladribine; dabrafenib; hairy cell leukemia; moxetumomab pasudotox; rituximab; vemurafenib
Online: 3 June 2021 (08:09:13 CEST)
REVIEW
|
doi:10.20944/preprints202307.1468.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
CLL; atypical CLL; CD5; CD23; CLL differential diagnosis.
Online: 21 July 2023 (09:07:06 CEST)
ARTICLE
|
doi:10.20944/preprints202209.0018.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
complication; dexamethasone; IMiD; infection; lenalidomide; multiple myeloma; neutropenia; Rd
Online: 1 September 2022 (09:46:28 CEST)
ARTICLE
|
doi:10.20944/preprints202207.0033.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
multiple myeloma; early mortality; blood plasma; circulating miRNA; hematological malignancies; molecular biomarker; multiparametric model; prognosissurvival
Online: 4 July 2022 (05:59:59 CEST)
ARTICLE
|
doi:10.20944/preprints202111.0498.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
bortezomib; IL-13; IL-1Ra; IL-4; multiple myeloma; OS; PFS
Online: 26 November 2021 (10:31:50 CET)
ARTICLE
|
doi:10.20944/preprints202012.0287.v2
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
ABCB1; bortezomib; CXCR4; gene expression; MAF; MARCKS; multiple myeloma; mRNA; POMP; PSMB5; refractory; RPL5; TXN; XBP1; sensitive
Online: 25 January 2021 (13:17:31 CET)